Clinical trial
A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET in the Detection of Beta Amyloid in Subjects With Probable Alzheimer's Disease, Older Healthy Volunteers, and Young Healthy Volunteers
NCT01680588 is registered in ClinicalTrials.gov with Navidea Biopharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET in the Detection of Beta Amyloid in Subjects With Probable Alzheimer's Disease, Older Healthy Volunteers, and Young Healthy Volunteers
- Lead sponsor
- Navidea Biopharmaceuticals
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2012
- Completion date
- December 31, 2018
- Enrollment
- 70 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.